Open AccessTreatment for Unresectable Hepatocellular Carcinoma
Author(s) -
Dibash Kumar Das
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000789304.89194.9b
Subject(s) - medicine , sorafenib , bevacizumab , hepatocellular carcinoma , oncology , cancer , malignancy , atezolizumab , clinical endpoint , surgery , clinical trial , chemotherapy , nivolumab , immunotherapy